Position history for DnB Asset Management AS's holdings in RECURSION PHARMACEUTICALS IN
DnB Asset Management AS previously held 0 shares of RXRX (RECURSION PHARMACEUTICALS IN), worth $0 as of 2025-Q4.
Final Value
$0
Final Shares
0
Total Value Change
-$248,061
Total Shares Change
-33,119
Other major holders of RXRX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BAILLIE GIFFORD & CO
Exited |
| 0 |
-100.0% |
| $0 |
| 0.0% |
| $4.11 |
0 |
| 2025-Q3 | New | 313,707 | - | $1.5M | 0.0% | $4.91 | 35 |
| 2025-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $5.03 | 0 |
| 2025-Q1 | Decreased | 18,917 | -77.8% | $100,071 | 0.0% | $5.81 | 0 |
| 2024-Q4 | New | 85,365 | - | $577,067 | 0.0% | $6.77 | 34 |
| 2024-Q3 | Exited | 0 | -100.0% | $0 | 0.0% | $6.98 | 0 |
| 2024-Q2 | New | 33,119 | - | $248,061 | 0.0% | $7.50 | 32 |